Sichuan Hongming Boshi Pharmaceutical

Sichuan Hongming Borui Pharmaceutical is a Chinese pharmaceutical company based in Chengdu, specializing in the research, development, and manufacturing of high-end chemical APIs and finished dosage forms. As a key subsidiary of the Sichuan Hongming Pharmaceutical Group, the company focuses on therapeutic areas such as oncology, cardiovascular diseases, and anti-infectives. Their portfolio includes significant generic products like Imatinib and Lenvatinib, alongside a pipeline of innovative small molecule drugs. The company operates state-of-the-art GMP-certified facilities designed for both large-scale production and specialized synthesis. In addition to its own product line, the company provides comprehensive CDMO services to global pharmaceutical partners.